June 6, 2025: Novo Nordisk Asked to Add NAION, Which Can Cause Blindness, to Ozempic Warning Label The European Medicines Agency has concluded that taking Ozempic and other medications that contain semaglutide may increase someones risk of developing NAION
The TGA reports a number of adverse events and other concerns received for unapproved peptide products, which include: severe allergic reactions, requiring doses of adrenaline and hospitalisation systemic inflammatory response syndrome (SIRS) (severe inflammation in the body), requiring hospital management generalised hypersensitivity symptoms such as fullbody intense itching, palpitations, pain and sweating wide ranging body side effects, including insomnia, blurred vision, extreme tiredness, flulike illness, joint pain and skin sensitivity musculoskeletal injuries, including plantar fasciitis and Achilles tendinitis, and poor product quality, including unsealed packaging from an online supplier
This breakthrough explained earlier findings that T cells infiltrate the PD brain
on the contrary, the amount of the lipid peroxidation product malondialdehyde increased in the same tissue (Bosch-Morell et al., 2009, 2011) have confirmed significant increased levels of lipid peroxidation and marked decrease in GSH, superoxide dismutase and catalase activities in the sciatic nerve of rats which were given alcohol for 10 weeks
The ongoing TRIUMPH-Outcomes trial (NCT06383390) will provide definitive data on whether these benefits translate into a reduction in major adverse cardiovascular events (MACE)